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Aim: To analyse, by means of a meta-analytical approach, the diagnostic accuracy of molecular biomarkers in gingival crevicular fluid (GCF) for the detection of periodontitis in systemically healthy subjects.
Material and Methods: Studies on GCF molecular biomarkers providing a binary classification table (or sensitivity and specificity values and group sample sizes) in individuals with clinically diagnosed periodontitis were considered eligible.
The search was performed using six electronic databases. The methodological quality of studies was assessed through the tool Quality Assessment of Diagnostic Studies. Meta-analyses were performed using the Hierarchical Summary Receiver Operating Characteristic, which adjusts classification data using random-effects logistic regression.
Results: The included papers identified 36 potential biomarkers for the detection of periodontitis and for 4 of them meta-analyses were performed. The median sensitivity and specificity were: for MMP8, 76.7% and 92.0%; for elastase, 74.6% and 81.1%; for cathepsin, 72.8% and 67.3% respectively. The worst estimates of sensitivity and specificity were for trypsin (71.3% and 66.1%, respectively). 
Conclusions: MMP8 showed good sensitivity and excellent specificity which resulted in this biomarker being clinically the most useful or effective for the diagnosis of periodontitis in systemically healthy subjects, regardless of smoking condition. 
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CLINICAL RELEVANCE
Scientific rationale for the study: Healthcare professionals looking for evidence about diagnostic tests may turn to systematic reviews of diagnostic test accuracy. 
Principal findings: MMP8 and elastase are the most researched GCF biomarkers, showing both a good capability to distinguish periodontitis patients and MMP8 an excellent capability to distinguish non-periodontitis patients. 


















In 2010, severe periodontitis was estimated to be the sixth most prevalent disease in the world, affecting 743 million people (Dentino et al., 2013). Periodontitis patients remain so for life, even following successful therapy, and require life-long supportive care to prevent the recurrence of the disease (Chapple et al., 2018). 
Gingival crevicular fluid (GCF) is a body fluid that can be easily collected and whose composition is the result of the interplay between the bacterial biofilm and the cells of the periodontium. GCF is, therefore considered to be the most promising medium for the detection of molecular biomarkers associated with periodontitis (Barros et al., 2016; Ghallab, 2018). 
In periodontics, the first challenge in treating periodontal disease is a timely and accurate diagnosis, as the loss of periodontal bone and soft tissue is incremental and largely irreversible (Kinane et al., 2017). Traditional clinical measures are the best currently available for diagnosing and monitoring the health-disease states in most patients, probably because they respond favourably to the key principles of periodontal care (Tonetti et al., 2018). However, researchers are striving to find faster, more sensitive and specific tools which could supplement or in some cases or settings replace the conventional clinical measurements for diagnosis of periodontitis (AlRowis et al., 2014; Ghallab, 2018).
The existence of a periodontitis-associated biomarker profile in GCF does not indicate its diagnostic capability (de Morais et al., 2018; Stadler et al., 2016). Investigations of diagnostic capability require the design of a specific accuracy study, which provides estimates of test performance (e.g., sensitivity and specificity) (McInnes et al., 2018). Healthcare professionals looking for evidence about diagnostic tests may turn to systematic reviews of diagnostic test accuracy (Leeflang, 2014). However, at present, we have not identified any systemic review/meta-analysis of the accuracy of molecular biomarkers in GCF for the diagnosis of periodontitis.
Consequently, this review aims to evaluate the accuracy of single molecular biomarkers detected in GCF for diagnosing periodontitis in systemically healthy subjects. 
MATERIALS AND METHODS
This systematic review/meta-analysis was prepared according to the Cochrane handbook on systematic reviews of diagnostic test accuracy, version 1.0.0 (Deeks & Bossuyt, 2013), and the PRISMA-DTA statement (McInnes et al., 2018). The completed PRISMA-DTA checklist is shown in Appendix S1.
The protocol was registered at the International Prospective Register of Systematic Reviews (PROSPERO) under the number CRD42018106045 (http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42018106045 (​http:​/​​/​www.crd.york.ac.uk​/​PROSPERO​/​display_record.asp?ID=CRD42018106045​)).
	PICO question
The formulated PICO question (patient, index test, comparison, outcome) was as follows: “In systemically healthy subjects, does the expression of single molecular biomarkers in GCF shows diagnostic capability of periodontitis when compared to clinical parameters?”.
	Criteria for considering studies for this review
Types of accuracy study
Studies on molecular biomarkers (index tests) in GCF that provided results on diagnostic accuracy in individuals with clinically diagnosed periodontitis (reference standard) were eligible for inclusion. Excluded were studies that did not report: 1) a contingency table for binary classification (2x2 table based on true positives, true negatives, false positives, false negatives); or 2) sensitivity and specificity values and sample sizes of the control and target conditions from which the estimation of classification table was possible. Prognostic and predictive accuracy studies were also excluded. 
Participants
The participants included in this review were patients without an explicit diagnosis of systemic disease and with a clinical periodontal diagnosis. 
Control and target conditions
The target conditions evaluated were chronic and aggressive periodontitis, regardless of the extent of the disease and the degree of severity. For the control condition, patients with a clinical diagnosis of periodontal health and gingivitis were considered. Studies of periodontitis patients in which the control and target conditions were defined at the site level according to PPD, CAL or BL parameters were also included.
Reference standard
The reference standard for the diagnosis of a periodontal condition was based on only clinical parameters (PPD or CAL) or clinical and radiographic parameters (BL), irrespective of the diagnostic benchmarks applied. Consequently, in the absence of homogeneous criteria, any definition based on the author’s reported criteria was accepted. A clinical periodontal diagnosis was viewed as a binary aspect of two categories, a control and a target condition, which was established at the patient or site level. 
Index test(s) 
Any single molecular biomarker detected in GCF, which was analysed from an accuracy analysis perspective, was considered to be an index test. Accuracy studies on multi-biomarkers or those detected in other fluids (e.g., blood) were excluded. 
Other exclusion criteria
The following types of study were excluded: thesis, dissertations, reviews, letters, personal opinions, book chapters, short communications, conference abstracts and patents. Other considerations used as exclusion criteria were the following: (i) no restrictions on the publication date of the papers, the type of setting or the publication status; and (ii) the articles had to be in English.
	Search methods for the identification and selection of studies
Information sources and search strategy
The search was conducted through the following electronic databases: Pubmed (Medline), Embase, the Cochrane Central Register of Controlled Trials and Trial Protocols, Scopus, Lilacs, and Web of Sciences (WoS).
The search strategies were created following recommendations established by the Cochrane Group (Deeks & Bossuyt, 2013). To reduce the loss of any relevant studies, any search filter based on methodological terms was avoided. Checks of the references of the included studies and other relevant reviews on the topic were also performed. The search strategy used in the different electronic databases was performed on October 25 2018, and it is detailed in Appendix S2.1.
Selection of studies using a dual procedure: data mining and manual methods
The manipulation of the data identified in the searches was carried out using the R software (version 3.4.3) and packages downloaded from the Comprehensive R Archive Network Team (2018)
</title><url>https://www.R-project.org/.</url><publication_date>99201800001200000000200000</publication_date><uuid>46CFA52C-9609-4748-A3EE-2200ECD64459</uuid><type>400</type><authors><author><lastName>Team</lastName><firstName>R</firstName><middleNames>Core</middleNames></author></authors></publication></publications><cites></cites></citation>(2018). Applying the search strategy with the resulting combination of terms, a total of 176 searches were performed in each database. 
In order to ensure research reproducibility (Norman et al., 2018), the abstracts of all the articles were analysed computationally. On a small number of previously selected diagnostic accuracy articles that met the inclusion criteria, it was confirmed that the automatic data mining process detected 100% of these papers. Only articles with multiple published identifiers (PMIDs), those with a single PMID that did not provide an abstract or those that did not have a designated PMID were analysed manually. Manual selection was conducted by two independent reviewers (N.A.B. and A.R.I.). A series of positive and negative words were defined, both in their singular and plural forms (Appendix S2.2). Those articles with at least one positive word and no negative word were selected as candidates for their full text to be assessed. The analysis of the positive and negative words was carried out using the tm package, version 0.7-5, and NLP package,version 0.1-11 (Feinerer et al., 2008; Hornik, 2017).
	Data collection and analysis
Selection of studies 
The analysis of the full texts of the candidate articles was carried out by two independent reviewers (N.A.B. and A.R.I.). If the reviewers disagreed, the decision about study eligibility was made by trying to reach a consensus between the two reviewers. Any continued disagreement was resolved by discussion with two different reviewers (I.T. and C.B.C.). The reasons for excluding studies were recorded.
	Data extraction and management
Four authors (N.A.B., A.R.I., I.T. and C.B.C.) independently extracted data in duplicate using a standardised data collection form. The first two authors focused on the characteristics of the studies, while the second two concentrated on the accuracy data. 
In particular, the following data were recorded from each study: the type of accuracy study; the characteristics of the patient groups; the characteristics on the reference standard; the number and type of control and target conditions; the characteristics of the GCF sample; type of molecular biomarker analysed and the technique used for its detection; and the accuracy results of the studies.
	Assessment of methodological quality
Two review authors (I.T. and C.B.C.) independently assessed the quality of the included studies using the critical review checklist of the revised Quality Assessment of Diagnostic Studies (QUADAS-2) (Whiting et al., 2011). The QUADAS-2 checklist was modified following the recommendations of Whiting et al. (2011). As the biomarkers evaluated in the review were quantified using "objective" methods, the question in domain 2 about blinding the test interpreter to the results of the reference standard was deleted (Appendix S3.1).
	Qualitative analysis
The unit of analysis was each 2x2 contingency table (confusion matrix) of a biomarker in GCF. In most studies, the biomarker results were reported on a continuous scale, such as the concentration or level of a quantifiable molecule. Consequently, these results were interpreted as positive or negative based on a numerical measurement that was categorised according to a biomarker classification threshold (pre-stated or not). If the classification data were not detailed in the article, the authors calculated the contingency table considering the sensitivity and specificity values and the sample size of the control and target groups. 
The establishment of the contingency table as a unit of analysis means that an article could show more than one table according to different control or target conditions and different techniques used for the quantification of the same biomarker. In those situations in which an article showed several contingency tables of the same biomarker for different classification thresholds and the same control and target conditions and the same applied technique, that table associated with the highest Younden’s index value was selected (Youden 1950).
Estimates of accuracy were expressed as sensitivity and specificity values, and with 95% confidence intervals (CIs), for each classification of a biomarker in GCF. They were then displayed as coupled forest plots. These graphics were created with the mada package, version 0.5.8 (Doebler, 2017). Other performance measures, such as the accuracy (ACC), the positive predictive value (PPV), the negative predictive value (NPV), the LR+, the negative likelihood ratio (LR-), the DOR and the Younden’s index, were also determined using the data extracted from each article (Appendix S4.1).
	Quantitative analysis
A meta-analysis was performed when the number of diagnostic classifications of a biomarker in GCF was reported in at least three articles. Because the biomarkers are continuous tests and the included studies all reported a different threshold for test positivity (Leeflang, 2014), Hierarchical Summary Receiver Operating Characteristic (HSROC) modelling was used to conduct the meta-analysis. The HSROC model directly estimates parameters, allowing the direct construction of a HSROC curve and including summary points of sensitivity and specificity (median values), together with their prediction and confidence region (Lee et al., 2015). 
The calculation of the HSROC model was performed using the HSROC package, version 2.1.8 (Schiller & Dendukuri, 2015), whereby estimations are carried out using a Bayesian approach, implemented via a Gibbs sampler (Schiller & Dendukuri, 2015). The HSROC package used to calculate meta-analyses implements a model for the joint meta-analysis of sensitivity and specificity of the diagnostic test under evaluation, mathematically taking into account the different sample sizes and the possible imperfections of sensitivity and specificity. This hierarchical model takes into account both variability within the study and variability between studies (Schiller & Dendukuri, 2015).
With the aim of trying to provide direct evidence for the usefulness or effectiveness of the GCF biomarkers subjected to meta-analytical analysis (Leeflang & Kraaijpoel, 2018), we presented the summary accuracy data (sensitivity and specificity estimators) derived from meta-analyses using natural frequencies based on a hypothetical cohort of 1000 patients for different prevalence of periodontitis (Whiting et al., 2018); subsequently these frequencies were converted into percentage values.
Investigations of heterogeneity




In total, 8410 articles were obtained from the six databases. Of these, 87.3% of the abstracts were studied using data-mining techniques and the remaining 12.7% using a manual procedure; a total of 120 full-text articles were assessed for eligibility. In addition, seven more articles were detected after studying the references from a list of reviews and full-text papers.
In the eligibility phase, 108 articles were excluded for various reasons (Appendix S5), and 19 papers and 69 contingency tables were selected for the qualitative analysis. After applying the established requirements for the meta-analysis, nine articles and 24 contingency tables were selected for the quantitative analysis. A detailed flow chart is shown in Figure 1.  
Characteristics of diagnostic accuracy studies in GCF
In 8/19 papers (42.1%), the authors investigated the diagnostic accuracy of only one biomarker in GCF, while the remaining 11/19 (57.9%) compared at least two biomarkers. A total of 36 individual molecular biomarkers were identified, of which: 20 (55.6%) were enzymes; eight (22.2%) were inflammatory and host-response mediators; five (13.9%) were periodontal breakdown-related products; and three (8.3%) were classified as "others". Twenty-one of the 36 biomarkers (58.3%) were only evaluated in a single article. 
Regarding the type of control condition, 59.3% of the classifications corresponded to healthy patients, and 25.0% to the combination of healthy patients and gingivitis patients. When the control condition was defined by subject and subgingival site, 37.8% of the contingency tables corresponded to subjects with chronic periodontitis and subgingival sites with no CAL. Regarding the type of target condition, 68.7% of the classifications corresponded to patients with chronic periodontitis; when the control condition was defined by subject and subgingival site, 37.8% of the contingency tables corresponded to subjects with chronic periodontitis and subgingival sites with CAL. Although in 11/19 papers (57.9%) nothing was specified about the smoking habit of the participants, in 5/19 (26.3%) study groups were composed of both smokers and non-smokers with a predominance of the last-mentioned.
Regarding the GCF collection protocol, the use of paper points or strips and periopapers are the most commonly used fluid collection methods (in 37% and 21% of the series, respectively); other aspects such as the storage temperature of the samples, the most frequent is storage at -80ºC for further processing (in 31.6% of the series). The most frequently applied techniques for the detection/quantification of biomarkers were colourimetric or fluorimetric methods (27.0%), multiparametric cytometry (14.9%) or ELISA (10.8%) (Table 1, Appendix S6). 
Quality assessment of diagnostic accuracy studies in GCF
Fourteen papers (73.7%) were case-control studies which conditioned patient selection domain was classified as high risk of bias in 16/19 articles (84.2%). However, practically all the studies met the requirements of a “single-gate design”. In the index text domain, the question about the application of a pre-specified threshold was judged as "no" in 15/19 articles (78.9%), indicating a high risk of bias. 
The reference standard correctly classified the periodontal condition without knowledge of the results of the index text in 16/19 articles (84.2%), so in these studies, the standard reference domain was associated with a low risk of bias. However, the authors mentioned calibration methods or the participation of calibrated professionals for the recording of clinical parameters in only six articles (31.6%). All patients in all included articles received the same reference standard, with 68.4% of them (13/19 articles) having an appropriate interval between the reference standard and the index test; this domain was considered low risk of bias in 11/19 articles (57.9%) (Figure 2 and Appendix S3.2). 
Considering the sample size as an indicator of quality, 83.3% of the contingency tables had ≤30 subjects in each group (control and target condition), while only 13.0% had >70 subjects. At the site level, larger sample sizes were detected; it was in 27.5% of the contingency tables that ≤30 fluid samples were analysed, while >70 were evaluated in 37.6% of the cases (Table 1).
Synthesis of the qualitative and quantitative analysis of four biomarkers
Only four of the 36 biomarkers had at least three classifications in at least three articles, and it was on these that the meta-analyses were performed. These molecules were all enzymes: matrix metalloproteinase (MMP) 8, 1907 control and target conditions/13 classifications/six articles (Baeza et al., 2016; Gul et al., 2016; Gul et al., 2017; Leppilahti et al., 2014; Mäntylä et al., 2003; Yuan et al., 2018); elastase, 1660/five/five (Eley & Cox, 1992a, 1992b; Gul et al., 2016, 2017; Ito et al., 2014); cathepsin, 1146/three/three (Eley & Cox, 1992a, 1992b; Gul et al., 2016); trypsin, 1146/three/three (Eley & Cox, 1992a, 1992b; Gul et al., 2016).
With the exception of trypsin, none of these biomarkers showed a threshold effect, either graphically or statistically. The ACC range (sensitivity and specificity ranges) were: 94.8-72.3% (96.8-64.4% and 98.3-77.6%) for MMP8; 88.9-69.7% (88.3-52.6% and 90.0-61.1%) for elastase; 82.2-53.3% (84.1-55.0% and 79.8-50.0%) for cathepsin; and 72.2-68.0% (80.0-71.0% and 68.1-56.7%) for trypsin (Figure 3 and Appendix S4.2). 
In meta-analyses, the median estimators of sensitivity and specificity ± standard deviation obtained were: 76.7 ± 13.4% and 92.0 ± 8.9% for MMP8; 74.6 ± 20.8% and 81.1 ± 19.2% for elastase; and 72.8 ± 23.5% and 67.3 ± 24.2% for cathepsin. The worst estimated sensitivity and specificity values were for trypsin (71.3 ± 17.5% and 66.1 ± 18.0%). Graphically, MMP8 was the biomarker that presented the narrowest prediction region, in which potential sensitivity and specificity values could be found in a future study. All four biomarkers showed a MC error value of sensitivity and specificity parameters smaller than 10% of its respective standard deviation, which means a high precision in the estimation of the parameters (Figure 4 and Appendix S7). Applying the premise of having at least three contingency tables of at least three articles, we performed various meta-analytical analyses of the MMP8 biomarker according to various selection criteria, the results of which are showed in Appendix S8.
In terms of usefulness or effectiveness of the two most studied GCF biomarkers (MMP8 and elastase), considering a 45% prevalence of periodontitis (Eke et al., 2016; Tonetti et al., 2015), 88.8% of the total MMP8 positive tests would indicate a true positive; while of the total MMP8 negative tests, 82.8% would show a true negative. For an elastase test, these percentages would be 79.7% and 76.4%, respectively (Figure 5).
Synthesis of the qualitative analysis of the remaining biomarkers
If we focus on those diagnostic classifications that presented better ACC values, above 90%, for diagnosis of periodontitis (sensitivity/specificity values), Baeza et al. (2016) obtained an ACC of 95.2% (93.5%/96.8%) for ProMMP2 and a value of 95.2% (96.8%/93.5%) for ProMMP9. For other enzymes, Leppilahti et al. (2014) detected an ACC of 94.7% (94.7%/94.7%) and 91.4% (94.7%/89.7%) for myeloperoxidase (MPO) and MMP14, respectively. Regarding inflammatory biomarkers, Tomás et al. (2017) observed that interleukin (IL) 1beta presented an ACC of 93.9% (93.2%/94.6%), while IL1alpha, an ACC of 93.2% (94.5%/91.9%) (Figure 6 and Appendix S4.3).

DISCUSSION
Quality of diagnostic accuracy studies in GCF and heterogeneity observed
Derived from our search process, the diagnostic accuracy literature on GCF molecular biomarkers in periodontitis represents less than 2% of the global literature and 38% of these studies did not meet the methodological requirements for inclusion in a systematic review on diagnostic accuracy (Macaskill et al., 2010). To the best of our knowledge, the present study is the first systematic review/meta-analysis of accuracy studies on GCF biomarkers for the diagnosis of periodontitis.
In terms of the methodological quality of the papers (Whiting et al., 2011), a predominance of case-control studies was detected (around 75%), which are known to be at higher risk of bias than cohort studies (Dinnes et al., 2005). However, it is important to emphasise a very positive characteristic present in practically all the included GCF articles, the presence of a “single-gate” design (Bossuyt & Leeflang, 2008; Leeflang, 2014). This design reflects reality better than the “two-gate” studies and are more likely to provide valid estimates of diagnostic accuracy (Leeflang, 2014), controlling possible imbalances between sensitivity and specificity values (Leeflang, 2014; Reistma et al., 2009). 
On the contrary, a predominant negative aspect associated with a high risk of bias in the index test domain is how the selection of the threshold takes place. In the present review, the authors did not apply pre-specified thresholds of the GCF molecular biomarkers in about 80% of the articles, but instead selected the threshold to optimise sensitivity and specificity. This way of proceeding undoubtedly leads to an overestimation of the performance of the test (Whiting et al., 2011). Although the threshold optimisation is a choice that can be adopted in the initial stages of the discovery of diagnostic biomarkers, a subsequent validation analysis in the article itself, whether internal or external, is fundamental when it comes to achieving robust results (Moons et al., 2015). However, of all the articles included in the present review, only the series recently published by Gul et al. (2017) and Tomás et al. (2017) included validation analysis. On the other hand, recently Gürsoy et al. (2018) proposed the cumulative use of salivary biomarkers with an adaptive-threshold design as an alternative to fixed biomarker thresholds in detection of periodontitis. 
In our opinion, this is a fundamental methodological limitation identified in the included studies related to the sample size of the control and target groups, since about 84% of the classifications had ≤30 subjects in each group. Fortunately, these data improved significantly when the analyses were carried out at the site level, although still 28% of the classifications had ≤30 subgingival sites. The performance results of an index test derived from a group of ≤30 subjects/sites are unreliable, because the variation in the classification of a single subject/site causes a modification of >3.3% in the sensitivity or specificity values. We believe that this requirement is of utmost importance in the methodological quality of a diagnostic accuracy study, and so its inclusion in the QUADAS-2 tool should be reconsidered.
Regarding heterogeneity related to the reference standard (clinical and radiological parameters), there are no universally accepted clinical diagnostic criteria for defining what a periodontitis case is (Zhang et al., 2009). Consequently, the variability of the definitions of the clinical phenotype of periodontitis in diagnostic accuracy studies had to be accepted to carry out this systematic review.
From a methodological point of view, the reference standard for the diagnosis of the periodontal condition based on only clinical (PPD or CAL) or clinical and radiographic parameters (BL) was considered the “gold standard”. This premise means that GCF biomarker accuracy estimates are calculated under the theoretical assumption that the reference standard is 100% sensitive and specific (Dinnes et al., 2005; Reistma et al., 2009). However, the well-recognised imprecision of the parameters described above (error-prone measures) and the application of heterogeneous clinical diagnostic criteria contribute to the fact that the reference standard is not "perfect" (Giannobile, 2012; Zhang et al., 2009); it can potentially lead to errors in the estimation of the diagnostic accuracy of GCF biomarkers (Dinnes et al., 2005). In the case of periodontitis, we believe that this possible verification bias will tend to underestimate biomarker accuracy since the reference standard and the index test measure different aspects of the disease (clinical and biological phenotypes), meaning that their possible errors are unrelated (Reistma et al., 2009). 
It has been stated that reported estimates of diagnostic accuracy may have limited clinical applicability (generalisability) if the spectrum of tested patients is not similar to the patients who would undergo the biomarker test in practice. In fact, studies that include severe cases and healthy controls tend to overestimate diagnostic performance (Dinnes et al., 2005; Reistma et al., 2009). Accordingly, in order to include a wide spectrum of patients for the GCF biomarkers under investigation, this review considered different control (e.g., subjects with good periodontal health or those with good periodontal health and gingivitis) and target conditions (e.g., different degrees of the extent and severity of chronic periodontitis). 
Regarding heterogeneity related to the detection of molecular biomarkers, we observed differences in methodological aspects of GCF collection. It is important to note that very low GCF volumes can have a dramatic effect on the concentrations of GCF biomarkers (Ghallab, 2018) and, consequently, on their diagnostic accuracy. It is also obvious that the GFC collection protocol and the type of technique applied can vary the detection and quantification of GCF biomarkers (Nazar Majeed et al., 2016). In the present study, the most frequently used techniques were colourimetric or fluorimetric methods, followed by multiparametric cytometry and ELISA techniques. Another consideration to be taken into account is how the manipulation of the data below the detection limit of the techniques was carried out (Uh et al., 2008); aspect that was not clarified in most of the papers included in the present systematic review.

Accuracy of biomarkers in GCF for the diagnosis of periodontitis
The first important observation to make is that there are a large number of individual biomarkers of a different nature, with up to 36 that have been evaluated from an accuracy perspective. The biomarkers are of different types, covering the three main biological phases of periodontitis (inflammatory, connective-tissue degradation and bone-turnover) (Miller et al., 2010). However, most of these observations are only described in a single article and are therefore unreliable, while only 4 (11%) were analysed in at least three publications. Our impression is that there is scientific attention about the initial discovery of GCF biomarkers for the diagnosis of periodontitis. There is, however, a lack of interest in confirming initial accuracy results, even though this is necessary if a biomarker is to be considered reliable. Based on the findings of this review, enzymes are, undoubtedly, the most researched biomarkers in the accuracy field, with the most studied of these being MMP8, followed by elastase, cathepsin and trypsin. 
MMPs are key proteases involved in periodontitis and are associated with periodontal status. From 2005 to date, there has been a significant increase in the number of studies that demonstrate both the association between MMP8 and various periodontal diseases and its high predictive capability. Indeed, some researchers have even commercialised several periodontitis and peri-implantitis diagnostic kits based on MMP8 (Sorsa et al., 2016). In a comprehensive review published by Sorsa et al. (2016), these authors stated: “antibodies originally described by themselves and used in Periomarker®, Periosafe®, Implantsafe® and Oral Risk Indicator® tests showed sensitivities of 0.83 and 0.95 and specificities of 0.96 and 0.98 for rapid point-of-care/chair-side and quantitative laboratory tests, respectively”. These authors support these accuracy data by referencing two papers: one conducted by Mäntylä et al. (2003) and one by Leppilahti et al. (2014).
In the present meta-analysis, MMP8 was the molecule associated with the best performance values, since it showed an estimated sensitivity and specificity median of 77% and 92%, respectively. However, unlike Sorsa et al. (2016), it was precisely the results of the previously cited paper by Mäntylä et al. (2003), which was included in our meta-analysis, that provided the worst sensitivity data (64% and 70%), negatively conditioning the estimation of the parameter.
Neutrophil elastase is an abundant proteinase released from the azurophilic granules of neutrophils; as a consequence, it is an indicator of neutrophil activity (Alfakry et al., 2016). The present review found that this molecule was the second most researched and had the second best performance values (estimated sensibility and specificity median= 75% and 81%). 
Our results should be interpreted with caution concerning other less researched GCF biomarkers. However, it is important to highlight the accuracy data of five biomarkers derived from the series where >30 subjects/sites were evaluated: MPO, IL1alpha, IL1beta, IL17A and IL6 (Baeza et al., 2016; Tomás et al., 2017). 
In terms of the influence of variables on the diagnostic accuracy of GCF biomarkers, we are especially interested in the smoking condition. Several studies have revealed that enzymes such as MMP8, elastase and MPO, or inflammatory mediators such as cytokines, have different profiles in the expressions or levels of these biomarkers in gingival tissue or GCF samples in periodontal smokers and non-smokers (Bunaes et al., 2017; Liu et al., 2006; Rai et al., 2010; Söder et al., 2002); this could significantly affect the accuracy of biomarkers for the diagnosis of periodontitis. However, despite the inclusion of both non-smokers and smokers in some of the included series, only one study took this variable into account, adjusting its predictive models and performance measures to this clinical variable (Tomás et al., 2017). 
Implications for practice
Recently, Tonnetti et al. (2018) recognised that biomarkers may contribute to improved diagnostic accuracy in the early detection of periodontitis and any assessment of its severity grade. A first-line test, also called a triage test, may be clinically useful even when the sensitivity or specificity is not high, depending on the steps that will be taken after testing (Leeflang, 2014). Considering a 45% prevalence of periodontitis associated with a broad spectrum of disease (Eke et al., 2016; Tonetti et al., 2015), theoretically, MMP8 test would be much more clinically useful or effective than elastase test. If we consider that MMP8 test in GCF was used as a first-line test to decide who should be referred for additional testing (Leeflang, 2014), there would be 17% of periodontitis subjects where the test would not be able to detect disease in initial screening, and on the other hand, only 11% of patients would be undergoing an unnecessary periodontal exploration.
Strengths and limitations
Diagnostic accuracy studies are described in different ways, and there is no standard terminology available (Leeflang, 2014). Given the magnitude of the search, after avoiding the application of search filters based on methodological terms, the use of a dual process (computerised and manual) for the selection of articles was mandatory. 
The dual search and selection process guaranteed that the articles included in our study accounted for the vast majority of all relevant diagnostic accuracy papers and that the final results were significant. We deliberately chose to include a wide spectrum of health and periodontitis in order to provide more realistic accuracy estimates for GCF biomarkers (Reistma et al., 2009). 
We did not perform tests to evaluate publication bias, as these can be misleading when they are applied to systematic reviews of diagnostic test accuracy (Leeflang et al., 2008; Tang & Liu, 2000).
The accuracy of a systematic review depends on the quantity and quality of the studies included. One of the main limitations of this review was that it did not have a higher number of series with large sample sizes in order to obtain more robust results from meta-analyses. Similarly, the limited number of classifications included for each biomarker did not allow us to perform analysis for heterogeneity or sensitivity analyses with which to evaluate the influence of covariates as the type of technique used for the quantification of biomarkers. 
Another general limitation in diagnostic accuracy reviews is that biomarkers analysed in different studies are compared. Comparisons between biomarkers should be ideally performed in the same series, in the same patients and against the same reference standard (Bruning et al., 2017).

Implications for research: future perspectives

Despite being a subject of great interest to the scientific community, in the current literature on diagnostic accuracy of single molecular biomarkers in GCF there is a predominance of individual results from a multitude of molecules; with MMP8 and elastase being the most researched biomarkers. On the other hand, a considerable number of studies are of questionable quality, especially involving series with small sample sizes. 
It is, therefore, necessary to perform sufficiently large, prospective, well-designed, multicentre studies that evaluate a number of GCF biomarkers for diagnosis of periodontitis (Dinnes et al., 2005). Also, these studies have to include a validation analysis, at least internal validation (Moons et al., 2015), and should also consider the influence of variables such as the presence of gingivitis in the control condition,  smoking and the presence of systemic diseases in order to refine the diagnostic accuracy results. This increase in high-quality evidence would allow other more exhaustive meta-analyses to be conducted, including threshold and heterogeneity analyses (Macaskill et al., 2010; Steinhauser et al., 2016). 
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Figure 1. Flow diagram of literature search and selection of the studies adapted from the Cochrane protocol (Deeks & Bossuyt 2013).
GCF: gingival crevicular fluid; MMP: matrix metalloproteinase.

Figure 2. Results on the quality evaluation of diagnostic accuracy studies in GCF included in the present systematic review, applying the modified QUADAS-2 tool (Whiting et al. 2011).

Figure 3. Forest plot with diagnostic test accuracy (sensitivity, specificity, and 95% Cis) of each contingency table of a biomarker presented at least three articles and on which the meta-analytical analyses were carried out.
MMP: matrix metalloproteinase. In the forest plot, sensitivity and specificity values are rounded and the biomarkers are listed according to the sensitivity value (from highest to lowest value). 
If the data of true positive, true negative, false positive and false negative values for each contingency table of a biomarker were not detailed in the article, the authors calculated this table considering the sensitivity and specificity values and the sample size of the control and target groups. In relation to the precise sensitivity and specificity values provided in the selected articles, the values of the calculated contingency tables mostly showed decimal values, which had to be rounded and sensitivity and specificity values recalculated. Values equal to zero were not allowed in the tables and were replaced by 0.5; in this way, we avoided infinite values in some measures of the binary classification test, e.g., in the DOR or the LR+.

Figure 4. Meta-analyses performed on the four biomarkers (MMP8, elastase, cathepsin and trypsin) using HSROC modelling.
MMP: matrix metalloproteinase.
HSROC includes summary points of sensitivity and specificity (median values; red-filled point), together with their prediction and confidence region. The prediction region (red dotted area) refers to potential sensitivity and specificity values that might be found in a future study by describing the full extent of the uncertainty of the summary points. This region can represent between-study heterogeneity (Harbord et al. 2007). The confidence region (blue red dotted area) is associated with the summary estimates of sensitivity and specificity jointly in the HSROC space, while it also accounts for their inverse association based on the included studies. This region does not, however, reflect the between-study heterogeneity (Dinnes et al., 2005). Each black circle represents a classification of a biomarker included in the meta-analysis, and its size is proportional to the sample size. 

Figure 5. Expression of summary accuracy data derived from meta-analyses using natural frequencies based on a hypothetical cohort of 1000 patients along different periodontitis prevalence values for the two most studied biomarkers in GCF (MMP8 and elastase) (Whiting et al. 2018). 
MMP: matrix metalloproteinase; TP: true positive, test is positive (indicates periodontitis and patient has periodontitis); FP: false positive, test is positive (indicates periodontitis but patient does not have periodontitis); TN: true negative, test is negative (indicates periodontitis not present and patients does not have periodontitis); FN: false negative, test is negative (indicates periodontitis not present but patients has periodontitis).  
The continuous lines indicate the percentage of positive tests for different prevalences of periodontitis (the blue one, the percentage of true positives and the red line, the percentage of false positives). Discontinuous lines indicate the percentage of negative tests for different prevalences of periodontitis (blue line, percentage of true negatives and red line, percentage of false negatives). 

Figure 6. Forest plot with diagnostic test accuracy (sensitivity, specificity, and 95% confidence interval) of each biomarker classification included, which presented less than three articles.
ALP: alkaline phosphatase; AST: aspartate aminotransferase; BG: beta-glucuronidase; COL: collagenase; DPP: dipeptidyl peptidase; MMP: matrix metalloproteinase; MPO: myeloperoxidase; T: total; TRAP: tartrate-resistant acid phosphatase; IL: interleukin; PG: prostanglandin; TNF: tumor necrosis factor; DKK: dickkopf-related protein; ON: osteonectin; OPG: osteoprotegerin; PTN: periostin; LPS: lipopolysaccharide. In the forest plot, sensitivity and specificity values are rounded and the biomarkers were listed in alphabetical order within each type of biomarker.
If these data of true positive, true negative, false positive and false negative values for each contingency table of a biomarker were not detailed in the article, the authors calculated this table considering the sensitivity and specificity values and the sample size of the control and target groups. In relation to the precise sensitivity and specificity values provided in the selected articles, the values of the calculated contingency tables mostly showed decimal values, which had to be rounded and sensitivity and specificity values recalculated. Values equal to zero were not allowed in the tables and were replaced by 0.5; in this way, we avoided infinite values in some measures of the binary classification test, e.g., in the DOR or the LR+.

Appendix S8. Meta-analyses performed on the MMP8 biomarker using HSROC modelling according to different criteria: selection of the contingency tables according to the best classification parameters (a); selection of the contingency tables based on healthy patients vs periodontitis patients (b); selection of the contingency tables in which MMP8 was determined by ELISA (c); selection of the contingency tables in which MMP8 was determined by IFMA (d).
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